GAJREE PHARMACY LIMITEDActive

Company number SC158396Private limited companyIncorporated 1995
⚠ Confirmation statement overdue. It was due on 31 Jul 2026.

Key figures

£1,930,512-0.6%
Net assets 2023/24
-0.8%
Average annual change 2019/20–2023/24
01 m2 m3 m2019/202020/212021/222022/232023/24

Like most small UK companies, GAJREE PHARMACY LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2023/24
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02 m4 m2019/202020/212021/222022/232023/24
Filed accounts2019/20–2023/24
2019/202020/212021/222022/232023/24
Cash at bank and in hand230,55640,293395,230414,036—
Total assets403,9092,048,5062,247,1692,917,5663,084,903
Total liabilities————1,154,391
Net assets / total equity1,991,4242,018,4061,451,0281,941,8861,930,512
Average number of employees11011

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: GAJREE PHARMACY LIMITED

Company

GAJREE PHARMACY LIMITED is a private limited company registered with Companies House under company number SC158396. It was incorporated on 5 Jun 1995. Its status is active. The registered office is in Glasgow (G46). Its nature of business (SIC 2007) is other letting and operating of own or leased real estate (68209).

Accounts

The latest accounts in the database are for 2023/24 (period ending 31 Jul 2024); the company files small company accounts (filleted). Net assets were £1,930,512, down 0.6% on the previous year. Total assets were £3,084,903 and total liabilities £1,154,391. The company had an average of 1 employee. Figures are available for 5 financial years (2019/20–2023/24).

Control and charges

One person with significant control is registered. 11 of 11 registered charges are outstanding.

Filing deadlines

The next accounts are due by 30 Apr 2027. The next confirmation statement is due by 31 Jul 2026.